Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 149, 18-26
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)BMC Endocrine Disorders, 2015
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care, 2014
- Diabetes in the Middle-East and North Africa: An updateDiabetes Research and Clinical Practice, 2014
- Clinical Inertia in People With Type 2 DiabetesDiabetes Care, 2013
- Expectations about insulin therapy, perceived insulin-delivery system social acceptability, and insulin treatment satisfaction contribute to decreases in insulin therapy self-efficacy in patients with type 2 diabetes after 36 weeks insulin therapy (2型糖尿病患Journal of Diabetes, 2013
- An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve studyDiabetes Research and Clinical Practice, 2011
- The economic and clinical benefits of adequate insulin initiation and intensification in people with type 2 diabetes mellitusDiabetes, Obesity and Metabolism, 2011
- Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic reviewJRSM Short Reports, 2011
- The Contribution of Pretreatment Expectations and Expectation-Perception Difference to Change in Treatment Satisfaction and End Point Treatment Satisfaction in the Context of Initiation of Inhaled Insulin Therapy in Patients with Type 2 DiabetesDiabetes Technology & Therapeutics, 2010
- The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c VariablesPLOS ONE, 2009